95 related articles for article (PubMed ID: 16836711)
1. Left ventricular lead proximity to an akinetic segment and impact on outcome of cardiac resynchronization therapy.
Arzola-Castaner D; Taub C; Kevin Heist E; Fan D; Haelewyn K; Mela T; Picard MH; Ruskin JN; Singh JP
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):623-7. PubMed ID: 16836711
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.
Singh JP; Fan D; Heist EK; Alabiad CR; Taub C; Reddy V; Mansour M; Picard MH; Ruskin JN; Mela T
Heart Rhythm; 2006 Nov; 3(11):1285-92. PubMed ID: 17074633
[TBL] [Abstract][Full Text] [Related]
3. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
[TBL] [Abstract][Full Text] [Related]
4. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
Bulava A; Lukl J
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
[TBL] [Abstract][Full Text] [Related]
5. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites.
Derval N; Steendijk P; Gula LJ; Deplagne A; Laborderie J; Sacher F; Knecht S; Wright M; Nault I; Ploux S; Ritter P; Bordachar P; Lafitte S; Réant P; Klein GJ; Narayan SM; Garrigue S; Hocini M; Haissaguerre M; Clementy J; Jaïs P
J Am Coll Cardiol; 2010 Feb; 55(6):566-75. PubMed ID: 19931364
[TBL] [Abstract][Full Text] [Related]
6. Does RV lead positioning provide additional benefit to cardiac resynchronization therapy in patients with advanced heart failure?
Shimano M; Inden Y; Yoshida Y; Tsuji Y; Tsuboi N; Okada T; Yamada T; Murakami Y; Takada Y; Hirayama H; Murohara T
Pacing Clin Electrophysiol; 2006 Oct; 29(10):1069-74. PubMed ID: 17038138
[TBL] [Abstract][Full Text] [Related]
7. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
8. Area of left ventricular regional conduction delay and preserved myocardium predict responses to cardiac resynchronization therapy.
Tse HF; Lee KL; Wan SH; Yu Y; Hoersch W; Pastore J; Zhu Q; Kenknight B; Spinelli J; Lau CP
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):690-5. PubMed ID: 16050824
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of a novel "response score" to predict hemodynamic and clinical outcome from cardiac resynchronization therapy.
Heist EK; Taub C; Fan D; Arzola-Castaner D; Alabiad CR; Reddy VY; Mansour M; Mela T; Picard MH; Ruskin JN; Singh JP
Am J Cardiol; 2006 Jun; 97(12):1732-6. PubMed ID: 16765123
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of right and left ventricular lead positions during the implantation of cardiac resynchronization therapy defibrillators.
Stockinger J; Staier K; Schiebeling-Römer J; Keyl C
Pacing Clin Electrophysiol; 2011 Nov; 34(11):1537-43. PubMed ID: 21797906
[TBL] [Abstract][Full Text] [Related]
11. Influence of left ventricular lead location on outcomes in the COMPANION study.
Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
[TBL] [Abstract][Full Text] [Related]
12. Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy.
Heist EK; Fan D; Mela T; Arzola-Castaner D; Reddy VY; Mansour M; Picard MH; Ruskin JN; Singh JP
Am J Cardiol; 2005 Sep; 96(5):685-90. PubMed ID: 16125496
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
[TBL] [Abstract][Full Text] [Related]
14. Effects of stimulation site on diastolic function in cardiac resynchronization therapy.
de Cock CC; Vos DH; Jessurun E; Allaart CP; Visser CA
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S40-2. PubMed ID: 17302714
[TBL] [Abstract][Full Text] [Related]
15. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.
Duckett SG; Ginks M; Shetty AK; Bostock J; Gill JS; Hamid S; Kapetanakis S; Cunliffe E; Razavi R; Carr-White G; Rinaldi CA
J Am Coll Cardiol; 2011 Sep; 58(11):1128-36. PubMed ID: 21884950
[TBL] [Abstract][Full Text] [Related]
16. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Vos DH; Elvan A; Ramdat Misier AR; Beukema WP; Steendijk P; van Hemel NM
Eur Heart J; 2009 Apr; 30(7):797-804. PubMed ID: 19202156
[TBL] [Abstract][Full Text] [Related]
17. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.
Cabrera-Bueno F; García-Pinilla JM; Peña-Hernández J; Jiménez-Navarro M; Gómez-Doblas JJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa-Galván E
Europace; 2007 Sep; 9(9):757-61. PubMed ID: 17573358
[TBL] [Abstract][Full Text] [Related]
18. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
Riedlbauchová L; Brunken R; Jaber WA; Popová L; Patel D; Lánská V; Civello K; Cummings J; Burkhardt JD; Saliba W; Martin D; Schweikert R; Wilkoff BL; Grimm R; Natale A
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):50-7. PubMed ID: 18803571
[TBL] [Abstract][Full Text] [Related]
19. Dual-site left ventricular cardiac resynchronization therapy.
Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
